Parameter
| Biomarker | METCAM | Full name | MET Cell Adhesion Molecule | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis, therapeutic targets |
| Disease | PCa | Disease Subtypes | / | ||
| Organ | Prostate | Test Sample / Technology Platform | Serum (ELISA), Tumor Tissue (Western Blot, WB) | ||
| Pathobiological Mechanisms | METCAM, as a cell membrane protein, is highly expressed in cancer tissues and promotes the epithelial-mesenchymal transition, migration, invasion and metastasis of prostate cancer cells. | ||||
| Clinical Availability Status | Research verification | ||||
| Notes and Dynamics | Based on its carcinogenic effects, METCAM can serve as a therapeutic target, with related treatment strategies currently under further investigation, and clinical trials may be advanced in the next phase. | ||||